- Home
- ESPR vs SERV Comparison
ESPR vs SERV Comparison
Compare ESPR & SERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESPR | SERV |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 724.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESPR | SERV |
|---|---|---|
| Price | $3.72 | $10.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.86 | ★ $18.33 |
| AVG Volume (30 Days) | 6.5M | ★ 7.1M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $303,802,000.00 | $1,944,483.00 |
| Revenue This Year | $25.45 | $44.11 |
| Revenue Next Year | N/A | $925.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.83 | ★ 15.76 |
| 52 Week Low | $0.69 | $4.66 |
| 52 Week High | $4.13 | $24.35 |
Technical Indicators
Market Signals| Indicator | ESPR | SERV |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 44.85 |
| Support Level | $3.72 | $11.50 |
| Resistance Level | $4.13 | $13.70 |
| Average True Range (ATR) | 0.24 | 1.00 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 23.15 | 24.16 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SERV Serve Robotics Inc.
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.